• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR OMNILINK ELITE PERIPHERAL STENT SYSTEM; PERIPHERAL STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR OMNILINK ELITE PERIPHERAL STENT SYSTEM; PERIPHERAL STENT DELIVERY SYSTEM Back to Search Results
Catalog Number 11011-39
Device Problems Difficult to Advance (2920); Device Dislodged or Dislocated (2923)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/26/2021
Event Type  malfunction  
Event Description
It was reported that the procedure was to treat a left iliac artery.While advancing a 8x39mm omnilink elite 35 delivery system over the guide wire (still outside the patient) resistance was met with the guide wire, then it was noted that the stent implant moved/slid backwards from the balloon.Another 8x39mm omnilink elite was used to successfully complete the procedure.There were no adverse patient effects and no clinically significant delay in the procedure.No additional information was provided.
 
Manufacturer Narrative
The device is expected to be returned for investigation.It has not yet been received.A follow-up report will be submitted with all additional relevant information.
 
Manufacturer Narrative
A visual, dimensional, and functional inspections were performed on the returned sds.The reported stent dislodgement was confirmed.The reported difficulty to advance the sds over the guide wire was unable to be confirmed and a proxy guide wire was able to advance and retract without any resistance noted.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other incidents reported from this lot.Factors that may contribute to the difficulty to advance/position the sds over the guide wire and cause resistance between the devices may include, but not limited to, manufacturing, device placement technique, guiding catheter support, anatomical conditions/patient anatomical morphology, inner diameter of guide wire lumen of sds device, outer diameter of the guide wire, condition of the guide wire, condition of the sds, coagulation of blood or procedural contaminates.Additionally, factors that can contribute to stent dislodgement may include, but not limited to; improper or inadequate crimping at the time of manufacture, incorrect sheath sizing, positive pressure during preparation, forced sheath removal, handling of the stent during preparation, and interaction with the lesion, accessory devices, and/or previously implanted stents.The investigation was unable to determine a conclusive cause for the reported difficulty to advance the sds over the guide wire and stent dislodgement.It is possible that the stent dislodgment occurred during removal of the protective sheath; however, this could not be confirmed.There is no indication of a product quality issue with respect to the design, manufacture or labeling of the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OMNILINK ELITE PERIPHERAL STENT SYSTEM
Type of Device
PERIPHERAL STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005718570 (P099)
cashel road
clonmel tipperary
EI  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key13046887
MDR Text Key284981680
Report Number2024168-2021-11905
Device Sequence Number1
Product Code NIO
Combination Product (y/n)N
Reporter Country CodeBU
PMA/PMN Number
P110043
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 02/02/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/31/2023
Device Catalogue Number11011-39
Device Lot Number0031941
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/20/2022
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/01/2021
Initial Date FDA Received12/20/2021
Supplement Dates Manufacturer Received01/31/2022
Supplement Dates FDA Received02/02/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured03/19/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
TERUMO 0.35/300 J STIFF GUIDEWIRE; TERUMO 6F SHEATH
Patient Age53 YR
Patient SexMale
Patient Weight75 KG
Patient RaceWhite
-
-